Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013

Pharmaceutical Sales & Brand Management Conference

08 Jul 2013 - 09 Jul 2013 - Las Vegas, NV , USA

Bookmark and Share

How does the pharmaceutical salesperson of the future delivery value?

The answer is no longer simple. What was once a standard operating procedure has been thrown into flux. The market is in the midst of a sea change and pharmaceutical companies are now re-evaluating brand & life cycle management, sales team design & incentives, physician & payer relationships and social media campaigns. Decisions made on these strategic issues will have a direct impact on the organization’s ability to grow as a brand.

However significant change brings new opportunity. The best strategic plans will chart new courses and create new market leaders. Sales teams of the future will solidify new bonds with customers driving brand value. New marketing campaigns will harness the voice of the customer to enhance public awareness. Access will be created by satisfying needs. But only those who understand this dynamic market and develop the best strategic tools will enjoy the successes this new future holds.

GTC’s Pharmaceutical Sales & Brand Management Conference assembles key strategic leaders to discuss and bring clarity to a transitioning market. They will discuss issues, including:
  · Incentivizing sales teams
  · Selling to managed care systems
  · Healthcare reform
  · Market access
  · Social media campaigns
  · Managing specialty drugs
  · Biologic strategies
  · ACOs and their relationships with pharma

This is a unique opportunity to hear from and network with your peers in an exclusive setting devoted entirely to pharmaceutical sales, marketing and brand management.

2013 Pharmaceutical Sales & Brand Management Conference Committee

Conference Advisory Board Members:
Dan Brennan, Vice President, Neurology,
Dan Camardo, Senior Director, Marketing Operations,
 Astellas Pharma US
Frank Dolan, Director, Synergy Sales Force,
 Amylin Pharmaceuticals
Christine Fiore, Compliance Business Partner, Commercial Compliance,
 Boehring Ingelheim
John Grano, Vice President, Global Sales & Marketing Effectiveness,
 Sanofi Pasteur
Kari K. Loeser, Compliance Counsel,
 Jazz Pharmaceuticals
Tom McCann, Vice President, Oncology Sales and Marketing,
 Accredo, a Division of Express Scripts

We look forward to seeing you at the conference!

Further information
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos